2025-06-19 - CoA - Alexion v. Samsung - UPC_CoA_402/2024

Aktenzeichen:
UPC_CoA_402/2024
Datum:
Spruchkörper:
Court of Appeal - Luxembourg (LU)
Art:
Application Order
Parteien:
Alexion Pharmaceuticals v. Samsung Bioepis

Kernaussage: The Court of Appeal sets out the general principles to be considered when deciding on a request for a rehearing based on a fundamental procedural defect pursuant to Art.

2025-06-19 - CoA - Alexion v. Samsung - UPC_CoA_402/2024
Eine Entscheidung, mehrere Registereinträge

Das Gericht hat diese Verfahren zusammen entschieden und dasselbe Dokument in jedem davon eingestellt. Jeder Eintrag unten ist ein eigener vollwertiger Registereintrag.

  • UPC_CoA_402/2024 (Sie lesen diesen hier) Text zuerst hier gespeichert
  • UPC_CoA_402/2024
🏛️Court of Appeal - Luxembourg (LU)• Application Order
📅2025-06-19
🔢UPC_CoA_402/2024
Parteien & Vertreter
Kläger / Berufungsführer
Alexion Pharmaceuticals, Inc.
Elena HENNECKE
Beklagter / Berufungsbeklagter
Samsung Bioepis NL B.V.
Peter MEYER
📋ORD_11880/2025
⚖️Generic application
🌐English

The Court of Appeal sets out the general principles to be considered when deciding on a request for a rehearing based on a fundamental procedural defect pursuant to Art. 81(1)(b) UPCA jo. R. 247(c) RoP (fundamental procedural defect; fundamental violation of Art. 76 UPCA)

The Court of Appeal rejected an application for a rehearing as not allowable, stating that the applicant had not shown that the CoA had erred in its judgement, let alone that there was a fundamental defect. The CoA went into detail regarding the respective rules (Art. 76 UPCA, Rule 247 RoP) and clarified the legal standard regarding an application to rehear a case. The decision was published twice for parallel proceedings against different Defendants.
Stichwörter
Rehearing (Art. 81(1) UPCA, fundamental procedural defect, R. 245 RoP

Entscheidung teilen

Weitere Navigation
Entscheidungen
Rechtstexte
Analysen

Zu Sammlung hinzufügen

0 Einträge hinzufügen zu:

Anmeldung

Registrieren